Observational studyHealth and quality of life outcomes2024

Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.

Elizabeth A Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.